Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer.
about
Identification of a variant in KDR associated with serum VEGFR2 and pharmacodynamics of PazopanibMET Suppresses Epithelial VEGFR2 via Intracrine VEGF-induced Endoplasmic Reticulum-associated DegradationGrowth Hormone Ameliorates the Radiotherapy-Induced Ovarian Follicular Loss in Rats: Impact on Oxidative Stress, Apoptosis and IGF-1/IGF-1R Axis.Functional FLT1 Genetic Variation is a Prognostic Factor for Recurrence in Stage I-III Non-Small-Cell Lung CancerNext-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations.Molecular Heterogeneity of Ewing Sarcoma as Detected by Ion Torrent SequencingTowards standardization of next-generation sequencing of FFPE samples for clinical oncology: intrinsic obstacles and possible solutions.Mutational analysis of pulmonary tumours with neuroendocrine features using targeted massive parallel sequencing: a comparison of a neglected tumour group.Comprehensive translational control of tyrosine kinase expression by upstream open reading frames.Identification of a Novel Pathogenic Germline KDR Variant in Melanoma.AKT1 and BRAF mutations in pediatric aggressive fibromatosis.Discovery and functional assessment of gene variants in the vascular endothelial growth factor pathwayDetermination of VEGFR-2 (KDR) 604A>G Polymorphism in Pancreatic Disorders.Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients.Targeted next-generation sequencing identifies molecular subgroups in squamous cell carcinoma of the head and neck with distinct outcome after concurrent chemoradiation.Advances and Applications of Ion Torrent Personal Genome Machine in Cutaneous Squamous Cell Carcinoma Reveal Novel Gene Mutations.KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer.Parallel targeted next generation sequencing of childhood and adult acute myeloid leukemia patients reveals uniform genomic profile of the disease.An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure.The VEGFR2, COX-2 and MMP-2 polymorphisms are associated with clinical outcome of patients with inoperable non-small cell lung cancer.α-Fetoprotein-Producing Hepatoid Gastric Adenocarcinoma With Osteoclast-Like Giant Cells and Neuroendocrine Differentiation: A Case Study With Molecular Profiling.Molecular subtype specific efficacy of MEK inhibitors in pancreatic cancersArchitecture of pharmacogenomic associations: structures with functional foundations or castles made of sand?Genetic variants in the KDR gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma.The relationship of kinase insert domain receptor gene polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients treated with sorafenib.Loss-of-function uORF mutations in human malignancies.Expanded molecular profiling of myxofibrosarcoma reveals potentially actionable targets.Somatic mutations in histiocytic sarcoma identified by next generation sequencing.Identification of Unique, Heterozygous Germline Mutation, STK11 (p.F354L), in a Child with an Encapsulated Follicular Variant of Papillary Thyroid Carcinoma within Six Months of Completing Treatment for Neuroblastoma.Molecular Screening of Small Biopsy Samples Using Next-Generation Sequencing in Korean Patients with Advanced Non-small Cell Lung Cancer: Korean Lung Cancer Consortium (KLCC-13-01).VEGFR-2, CXCR-2 and PAR-1 germline polymorphisms as predictors of survival in pancreatic carcinoma.Vascular endothelial growth factor receptor 2 gene polymorphisms as predictors for tumor recurrence and overall survival in non-small-cell lung cancer.Genetic variations in the VEGF pathway as prognostic factors in metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy.
P2860
Q35068932-E288DD3E-4F07-4D9A-A54F-C42CEDB641E4Q35800730-1816CDAE-43BA-425B-AC9F-237F2E8D35D5Q35806248-3D8C06D5-4A93-4F45-991A-DEA9ED368710Q35826391-2417114E-CA45-45B4-9C80-BC1107905756Q35842446-3341525D-A50D-485D-BE91-4F54FDA1E15BQ35989684-F700D61E-280B-49DD-86C9-B7C8DF453EE2Q36264188-51356F77-4B24-4928-8EB9-360AE83B8902Q36432090-8CD53805-A9B7-4F16-A56C-9C2FD141C508Q36764779-8CA68447-D1F1-4728-A83F-7F1FCF9226DCQ36902033-220D19F2-F145-413F-991A-7FE53736EDAAQ37045567-57356967-007A-4729-A153-135CACA7784EQ37604560-2462C8B6-8BF4-4420-9A7D-9B47A44F1CF0Q37691036-1EFA70A9-8ACA-497A-A46F-C00CFE6BCD8FQ38285850-566B2D71-8BF0-487B-83FE-0BCD2CDF0D28Q38378172-001C94D4-5427-4D1C-82A8-CF52D153B87CQ38854526-9D67A7CC-0A40-4E4E-983C-A0A950CC7ED4Q38985125-B7A5A7DA-4707-4CFC-92A1-8FB5D4E13558Q39558408-A4A6AC8A-26DF-4397-8431-5EF2C1833327Q40452107-40840F57-5AA9-47BA-AF3A-FE5B1AB32099Q40939223-EBB73623-67D8-42FC-B403-5F6C8941C2A6Q41718367-15E66D4A-87D1-4DF1-930E-6B5937C8D7F4Q42366316-19AF08BB-95DF-4FA1-B222-C7D2F79DF930Q42781674-FA5E7B21-5825-4119-9542-F330990B0F54Q44365750-BAAEF5A3-2001-4083-869E-D135C19F0C22Q44479261-05714331-BF3D-4A88-ACC3-B98F511317ADQ48103359-8DB01A7C-A575-46C4-956A-BE720916B175Q48292408-B988ED27-1DF6-4BC3-AEC5-A0F39BA5C772Q50891287-FD0DE6C9-80A5-4371-BBD3-177E0FD9A992Q51047359-F8B36C0A-499A-4C41-9800-603CC0662545Q52724325-477CFB76-C601-4A69-810E-7899945B0780Q54276966-65DCD779-F34E-4E73-BE6D-4F82B5E040BDQ54320364-47CBA0AE-BA85-496B-9962-A22454F2BDF8Q55067016-EEA00AD3-AD77-4865-809F-44AD78E80A87
P2860
Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Novel functional germline vari ...... vessel density in lung cancer.
@ast
Novel functional germline vari ...... vessel density in lung cancer.
@en
type
label
Novel functional germline vari ...... vessel density in lung cancer.
@ast
Novel functional germline vari ...... vessel density in lung cancer.
@en
prefLabel
Novel functional germline vari ...... vessel density in lung cancer.
@ast
Novel functional germline vari ...... vessel density in lung cancer.
@en
P2093
P2860
P1476
Novel functional germline vari ...... vessel density in lung cancer.
@en
P2093
Alexandra Giese
Dylan M Glubb
Elisa Cerri
Emma E Thompson
Federico Innocenti
Fred R Hirsch
Kurt Ballmer-Hofer
Mark W Lingen
Osman Mirza
Peixian Chen
P2860
P304
P356
10.1158/1078-0432.CCR-11-0379
P407
P577
2011-06-28T00:00:00Z